KDIGO is updating The 2021 Clinical Practice Guideline for the Management of Glomerular Diseases on an ongoing, chapter-by-chapter basis.
The KDIGO 2024 Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) is available for public review through Monday, September 30. The update takes into consideration evidence from randomized controlled trials published through April 2023. Brad Rovin, MD (United States), and Jürgen Floege, MD (Germany) co-chaired the guideline chapter updates and the 2021 KDIGO Glomerular Diseases Guideline.
KDIGO invites you to review this chapter update and share your candid comments and suggestions. Download the IgAN/IgAV Guideline Public Review Draft and Data Supplement from the Guideline Suite and provide comments via the feedback survey (below). Based on the feedback received during this open comment period, a final revised version will be prepared for publication.
Please note that by agreeing to provide feedback on a KDIGO draft guideline document, you permit KDIGO to acknowledge your participation as a reviewer in the final publication. Please also note that only completed surveys will be acknowledged.
Thank you in advance for your time and support. We look forward to hearing from you.
DISCLAIMER: USE OF THE CLINICAL PRACTICE GUIDELINES
This Clinical Practice Guideline is based upon the best information available at the time of publication. The recommendations are designed to provide information and assist decision-making. They are not intended to define a standard of care, and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every health care professional making use of this Guideline is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. The recommendations for research contained within this document are general and do not imply a specific protocol.
